Federated Hermes, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Federated Hermes, Inc.
- $43.9 Billion
- Q1 2025
A detailed history of Federated Hermes, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 439,884 shares of HRMY stock, worth $15.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
439,884
Previous 492,803
10.74%
Holding current value
$15.4 Million
Previous $17 Million
13.91%
% of portfolio
0.03%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding HRMY
# of Institutions
278Shares Held
44.8MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$232 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$204 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$165 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$55.3 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$45.1 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.07B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...